The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer, W. H.
Right arrow Articles by Hugli, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, W. H.
Right arrow Articles by Hugli, T. E.
The Journal of Immunology, 1999, 162: 453-459.
Copyright © 1999 by The American Association of Immunologists

Regulation of IL-6 Synthesis in Human Peripheral Blood Mononuclear Cells by C3a and C3adesArg1

Wolfgang H. Fischer2,3, Mark A. Jagels2 and Tony E. Hugli4

Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037

The anaphylatoxin C3a has been reported to have immunomodulatory effects on a number of different cell types. In this study we investigated the effects of C3a and C3adesArg on gene expression and protein secretion of IL-6 in human PBMCs, either alone or in combination with LPS or IL-1ß. C3a or C3adesArg alone exhibited no effect on the expression or secretion of IL-6. However, when PBMC were stimulated with LPS or IL-1ß, both C3a and C3adesArg were found to enhance IL-6 release by PBMC in a dose-dependent manner. Since C3a has been shown to induce PGE2 production by monocytes, and PGE2 has been shown to influence cytokine production, we investigated the potential role of PGE2 in C3a-mediated enhancement of LPS- and IL-1ß-induced IL-6 production. Indomethacin blocked PGE2 release, but had no influence on the observed effects of C3a, suggesting that the effects of C3a on IL-6 production are independent of PGE2 formation by monocytes. Northern blot analysis showed that C3a as well as C3adesArg enhanced LPS-induced mRNA levels for IL-6. Pretreatment of PBMCs with pertussis toxin blocked the functions of C3a and C3adesArg, indicating that the actions of these two molecules are mediated by a G protein-coupled pathway. Furthermore, we investigated the effects of C3a and C3adesArg on induction of NF-{kappa}B and activating protein-1 binding. Both molecules enhanced LPS-induced NF-{kappa}B and activating protein-1 binding activity. These results demonstrate the capacity of intact C3a and its circulating des-Arg form to exert immunmodulatory effects in vitro.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. M. Markiewski and J. D. Lambris
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
Am. J. Pathol., September 1, 2007; 171(3): 715 - 727.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Purwar, M. Wittmann, J. Zwirner, M. Oppermann, M. Kracht, O. Dittrich-Breiholz, R. Gutzmer, and T. Werfel
Induction of C3 and CCL2 by C3a in Keratinocytes: A Novel Autocrine Amplification Loop of Inflammatory Skin Reactions
J. Immunol., October 1, 2006; 177(7): 4444 - 4450.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Ritis, M. Doumas, D. Mastellos, A. Micheli, S. Giaglis, P. Magotti, S. Rafail, G. Kartalis, P. Sideras, and J. D. Lambris
A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways
J. Immunol., October 1, 2006; 177(7): 4794 - 4802.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. L. Mueller-Ortiz, T. J. Hollmann, D. L. Haviland, and R. A. Wetsel
Ablation of the complement C3a anaphylatoxin receptor causes enhanced killing of Pseudomonas aeruginosa in a mouse model of pneumonia
Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L157 - L165.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Kalant, R. MacLaren, W. Cui, R. Samanta, P. N. Monk, S. A. Laporte, and K. Cianflone
C5L2 Is a Functional Receptor for Acylation-stimulating Protein
J. Biol. Chem., June 24, 2005; 280(25): 23936 - 23944.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Boos, I. L. Campbell, R. Ames, R. A. Wetsel, and S. R. Barnum
Deletion of the Complement Anaphylatoxin C3a Receptor Attenuates, Whereas Ectopic Expression of C3a in the Brain Exacerbates, Experimental Autoimmune Encephalomyelitis
J. Immunol., October 1, 2004; 173(7): 4708 - 4714.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Recinos III, B. K. Carr, D. B. Bartos, I. Boldogh, J. R. Carmical, L. M. Belalcazar, and A. R. Brasier
Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway
Physiol Genomics, September 16, 2004; 19(1): 131 - 142.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. W. Strey, M. Markiewski, D. Mastellos, R. Tudoran, L. A. Spruce, L. E. Greenbaum, and J. D. Lambris
The Proinflammatory Mediators C3a and C5a Are Essential for Liver Regeneration
J. Exp. Med., September 15, 2003; 198(6): 913 - 923.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Inal, B. Schneider, M. Armanini, and J. A. Schifferli
A Peptide Derived from the Parasite Receptor, Complement C2 Receptor Inhibitor Trispanning, Suppresses Immune Complex-Mediated Inflammation in Mice
J. Immunol., April 15, 2003; 170(8): 4310 - 4317.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Kalant, S. A. Cain, M. Maslowska, A. D Sniderman, K. Cianflone, and P. N. Monk
The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein
J. Biol. Chem., March 21, 2003; 278(13): 11123 - 11129.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Monari, T. R. Kozel, F. Bistoni, and A. Vecchiarelli
Modulation of C5aR Expression on Human Neutrophils by Encapsulated and Acapsular Cryptococcus neoformans
Infect. Immun., July 1, 2002; 70(7): 3363 - 3370.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. Paparella, T.M. Yau, and E. Young
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update
Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 232 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Drouin, J. Kildsgaard, J. Haviland, J. Zabner, H. P. Jia, P. B. McCray Jr., B. F. Tack, and R. A. Wetsel
Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and Asthma
J. Immunol., February 1, 2001; 166(3): 2025 - 2032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.